Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats

By Nakachi N.   Kiuchi Y.   Inagaki M.   Inazu M.   Yamazaki Y.   Oguchi K.  

European Journal of Pharmacology, Vol. 281, Iss. 2, 1995-08 ,pp. : 195-203

Elsevier

Access to resources Recommend Favorite

Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes

By Cowell R.M.   Kantor L.   Hewlett G.H.K.   Frey K.A.   Gnegy M.E.  

European Journal of Pharmacology, Vol. 389, Iss. 1, 2000-02 ,pp. : 59-65

Elsevier

Access to resources Recommend Favorite

Enhanced striatal dopamine D 2 receptor-induced [ 35 S]GTP S binding after haloperidol treatment

By Geurts M.   Hermans E.   Maloteaux J.-M.  

European Journal of Pharmacology, Vol. 382, Iss. 2, 1999-10 ,pp. : 119-127

Elsevier

Access to resources Recommend Favorite

Barakol, a natural anxiolytic, inhibits striatal dopamine release but not uptake in vitro

By Thongsaard W.   Pongsakorn S.   Sudsuang R.   Bennett G.W.   Kendall D.A.   Marsden C.A.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 157-164

Elsevier

Access to resources Recommend Favorite

Effects of the D 3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release in rats

By Lagos P.   Scorza C.   Monti J.M.   Jantos H.   Reyes-Parada M.   Silveira R.   Ponzoni A.  

European Neuropsychopharmacology, Vol. 8, Iss. 2, 1998-05 ,pp. : 113-120

Elsevier

Access to resources Recommend Favorite